Sunday, January 01, 2006
Roche sub-license for Tamiflu
Roche,the mfr of patented drug Oseltamivir, considered effective for treating avian influenza, sub-licensed production to Indian firm Hetero Drugs Limited for supply in India and other developing countries. A wise decision considering the fact that Hetero beagn investing in Oseltaminvir two and half years ago and recd Indian govt approval for production and marketing. Strategic Partnering with fast caching-up Indian firms is a new trend and can be expected to continue in the same way firms partner with competitors in fast moving consumer elctronic products.